CAMERON PAPPAS: Open Payments
NPI 1104579986 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,588 in 209 payments from 21 companies in 2025. Trend: 2023 $3,546 · 2024 $7,208 · 2025 $7,588
Food & beverage: $6,427Consulting: $750Travel & lodging: $398Education: $13
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 12 | $1,511 |
| Janssen Biotech, Inc. | 36 | $1,031 |
| ABBVIE INC. | 39 | $918 |
| Regeneron Healthcare Solutions, Inc. | 19 | $604 |
| Incyte Corporation | 16 | $526 |
| Organogenesis Inc. | 7 | $474 |
| GENZYME CORPORATION | 18 | $422 |
| Lilly USA, LLC | 11 | $378 |
| Galderma Laboratories, L.P. | 16 | $358 |
| UCB, Inc. | 13 | $334 |
Products named: Zoryve, TREMFYA, DUPIXENT, SKYRIZI, RINVOQ, OPZELURA, NEMLUVIO, Bimzelx.
Industry payments across SC — which companies pay providers there.
